Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Aug 16, 2016 · 10-Q · 47 days after period end · 0001654954-16-001658
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $0.00 | $1.71K | $0.00 | $0.00 |
| Net Income | -$481.31K | -$517.51K | -$765.51K | -$152.97K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 16, 2016 · 47 d after period end
